Chemotherapy: Target Therapy and Immunotherapy:@0.423628:0.035749:0.914577:0.035749:0.914577:0.019993:0.423628:0.019993:0.015644:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005330:0.007177:0.013143:0.005809:0.012950:0.012508:0.006523:0.005330:0.008197:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.013143:0.011738:0.013181:0.005330:0.004349:0.018049:0.018049:0.011699:0.011738:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314
TREATMENT APPROACHES:@0.983689:0.278245:0.983689:0.065272:0.955679:0.065272:0.955679:0.278245:0.000000:0.000000:0.000000:0.057096:-0.123230:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.375913
13:@0.955522:0.038184:0.976595:0.038184:0.976595:0.018587:0.955522:0.018587:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.679047:0.970015:0.915156:0.970015:0.915156:0.956010:0.679047:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
OTHER SIDE EFFECTS:@0.084242:0.096122:0.283936:0.096122:0.283936:0.078306:0.084242:0.078306:0.017960:0.008980:0.014539:0.011118:0.012401:0.005987:0.011118:0.005987:0.014966:0.011118:0.005987:0.011118:0.010263:0.010263:0.011118:0.016677:0.008980:0.011118
Less common side  effects include skin :@0.084242:0.113546:0.480469:0.113546:0.480469:0.097790:0.084242:0.097790:0.008890:0.012508:0.007466:0.007466:0.013297:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.013297:0.007466:0.003848:0.013181:0.012508:0.005330:0.007978:0.012508:0.006094:0.006042:0.012508:0.012450:0.006523:0.007466:0.013297:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.013297:0.007466:0.009660:0.003848:0.011738:0.005330
erythema,  dry  skin,  fingernail  changes, :@0.084242:0.129818:0.480490:0.129818:0.480490:0.114062:0.084242:0.114062:0.012508:0.005792:0.010314:0.006523:0.011738:0.012508:0.018049:0.013143:0.005330:0.005330:0.008419:0.013181:0.005792:0.010314:0.005330:0.008430:0.007466:0.009660:0.003848:0.011738:0.005330:0.005330:0.008430:0.004686:0.004686:0.011738:0.012950:0.012508:0.006181:0.011738:0.013143:0.003848:0.003848:0.005330:0.008438:0.012450:0.011738:0.013143:0.011738:0.012950:0.012508:0.007466:0.005330:0.005330
xerostomia, water retention,  and sexual :@0.084242:0.146089:0.480480:0.146089:0.480480:0.130333:0.084242:0.130333:0.009236:0.012508:0.005711:0.012604:0.007466:0.006523:0.012604:0.018049:0.003848:0.013143:0.005330:0.011238:0.015990:0.013143:0.006523:0.012508:0.005792:0.011238:0.005713:0.012508:0.006523:0.012508:0.011738:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330:0.005892:0.013143:0.011738:0.013181:0.011238:0.007466:0.012508:0.009236:0.011699:0.013143:0.003848:0.005330
dysfunction  and  impotence.  Specific :@0.084242:0.162361:0.480484:0.162361:0.480484:0.146605:0.084242:0.146605:0.013181:0.010314:0.007466:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.015746:0.013143:0.011738:0.013181:0.005330:0.015750:0.003848:0.018049:0.013123:0.012604:0.006523:0.012508:0.011738:0.012450:0.012508:0.005330:0.005330:0.015746:0.009583:0.013123:0.012508:0.012450:0.003848:0.004686:0.004686:0.012450:0.005330
chemotherapeutic  agents cause distinct :@0.084242:0.178633:0.480482:0.178633:0.480482:0.162877:0.084242:0.162877:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.012508:0.011699:0.006523:0.003848:0.012450:0.005330:0.003502:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.008852:0.012450:0.013143:0.011699:0.007466:0.012508:0.008852:0.013181:0.003848:0.007466:0.006523:0.003848:0.011738:0.012450:0.006523:0.005330
toxicities,  including  cardiac toxicity  (dox-:@0.084242:0.194905:0.475156:0.194905:0.475156:0.179149:0.084242:0.179149:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.003848:0.012508:0.007466:0.005330:0.005330:0.003086:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.003848:0.011738:0.012950:0.005330:0.003085:0.012450:0.013143:0.005677:0.013181:0.003848:0.013143:0.012450:0.008428:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.010314:0.005330:0.003088:0.007100:0.013181:0.012604:0.009236:0.006388
orubicin)  and  interstitial lung disease :@0.084242:0.211177:0.480485:0.211211:0.480485:0.195455:0.084242:0.195421:0.012604:0.005792:0.011699:0.013123:0.003848:0.012450:0.003848:0.011738:0.007100:0.012434:0.012450:0.013143:0.011738:0.013181:0.012450:0.012450:0.003848:0.011738:0.006523:0.012508:0.005792:0.007466:0.006523:0.003848:0.006523:0.003848:0.013143:0.003848:0.012450:0.003848:0.011699:0.011738:0.012950:0.012450:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.695091
48:@0.166445:0.205592:0.178875:0.205592:0.178875:0.196407:0.166445:0.196407:0.006215:0.006215
(bleomycin).:@0.084246:0.227483:0.202259:0.227483:0.202259:0.211727:0.084246:0.211727:0.007100:0.013123:0.003848:0.012508:0.012604:0.018049:0.010314:0.012450:0.003848:0.011738:0.007100:0.005330
57:@0.202262:0.221870:0.214692:0.221870:0.214692:0.212684:0.202262:0.212684:0.006215:0.006215
TARGETED THERAPIES  :@0.084242:0.260691:0.328811:0.260691:0.328811:0.241094:0.084242:0.241094:0.009878:0.017404:0.013641:0.019756:0.012230:0.009878:0.012230:0.016463:0.006585:0.009878:0.015993:0.012230:0.013641:0.017404:0.013170:0.006585:0.012230:0.012230:0.006562:0.006585
AND IMMUNOTHERAPY:@0.084242:0.279915:0.340124:0.279915:0.340124:0.260319:0.084242:0.260319:0.017404:0.017404:0.016463:0.006585:0.006585:0.021167:0.021167:0.015052:0.017404:0.019756:0.009878:0.015993:0.012230:0.013641:0.017404:0.013170:0.014581
Targeted therapy should be distinguished :@0.084242:0.298479:0.480470:0.298479:0.480470:0.282723:0.084242:0.282723:0.007197:0.013143:0.005809:0.012950:0.012508:0.006523:0.012508:0.013181:0.006947:0.006523:0.011738:0.012508:0.005792:0.013133:0.013123:0.010314:0.006947:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.006947:0.013123:0.012508:0.006947:0.013181:0.003848:0.007466:0.006523:0.003848:0.011738:0.012950:0.011699:0.003848:0.007466:0.011738:0.012508:0.013181:0.005330
from  chemotherapy.  Targeted therapies :@0.084242:0.314751:0.480497:0.314751:0.480497:0.298995:0.084242:0.298995:0.006042:0.005711:0.012604:0.018049:0.005330:0.005415:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011724:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005330:0.005417:0.007197:0.013143:0.005807:0.012950:0.012508:0.006523:0.012508:0.013181:0.010757:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.003848:0.012508:0.007466:0.005330
are a relatively new class of anticancer :@0.084242:0.331022:0.480513:0.331022:0.480513:0.315266:0.084242:0.315266:0.013143:0.005715:0.012508:0.009487:0.013143:0.009487:0.005713:0.012508:0.003848:0.013143:0.006523:0.003848:0.010660:0.012508:0.003848:0.010327:0.009487:0.011738:0.012508:0.015990:0.009487:0.012450:0.003848:0.013143:0.007466:0.007466:0.009487:0.012604:0.006042:0.009487:0.013143:0.011738:0.006523:0.003848:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330
agents  that  can  overcome  many  of  the :@0.084242:0.347294:0.480486:0.347294:0.480486:0.331538:0.084242:0.331538:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005330:0.003275:0.006523:0.011738:0.013143:0.006523:0.005330:0.003273:0.012450:0.013143:0.011738:0.005330:0.003277:0.012604:0.010660:0.012508:0.005653:0.012450:0.012604:0.018049:0.012508:0.005330:0.003273:0.018049:0.013143:0.011738:0.010314:0.005330:0.003281:0.012604:0.006042:0.005330:0.003275:0.006523:0.011738:0.012508:0.005330
effects seen with cytotoxic treatments. Tar-:@0.084242:0.363566:0.475163:0.363566:0.475163:0.347810:0.084242:0.347810:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466:0.003983:0.007466:0.012508:0.012508:0.011738:0.003983:0.015990:0.003848:0.006523:0.011738:0.003983:0.012450:0.010314:0.006523:0.012604:0.006523:0.012604:0.009236:0.003848:0.012450:0.003983:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.007466:0.005330:0.003983:0.007197:0.013143:0.005792:0.006388
geted therapies can be classified into two :@0.084242:0.379838:0.480488:0.379838:0.480488:0.364082:0.084242:0.364082:0.012950:0.012508:0.006523:0.012508:0.013181:0.005080:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.003848:0.012508:0.007466:0.005088:0.012450:0.013143:0.011738:0.005088:0.013123:0.012508:0.005088:0.012450:0.003848:0.013143:0.007466:0.007466:0.003864:0.004686:0.004686:0.012508:0.013181:0.005084:0.003848:0.011738:0.006523:0.012604:0.005082:0.006523:0.015990:0.012604:0.005330
groups: small molecule  and antibodies. :@0.084242:0.396110:0.480486:0.396110:0.480486:0.380354:0.084242:0.380354:0.012950:0.005709:0.012604:0.011699:0.013123:0.007466:0.005330:0.011699:0.007466:0.018049:0.013143:0.003848:0.003848:0.011699:0.018049:0.012604:0.003848:0.012508:0.012450:0.011699:0.003848:0.012508:0.005330:0.006360:0.013143:0.011738:0.013181:0.011699:0.013143:0.011738:0.006523:0.003848:0.013123:0.012604:0.013181:0.003848:0.012508:0.007466:0.005330:0.005330
The toxicity associated with the usage of :@0.084242:0.412382:0.480463:0.412382:0.480463:0.396626:0.084242:0.396626:0.008197:0.011738:0.012508:0.007582:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.010314:0.007582:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.007582:0.015990:0.003848:0.006523:0.011738:0.007582:0.006523:0.011738:0.012508:0.007582:0.011699:0.007466:0.013143:0.012950:0.012508:0.007582:0.012604:0.006042:0.005330
cytotoxics is primarily due to the lack of cell :@0.084242:0.428654:0.480476:0.428654:0.480476:0.412898:0.084242:0.412898:0.012450:0.010314:0.006523:0.012604:0.006523:0.012604:0.009236:0.003848:0.012450:0.007466:0.003762:0.003848:0.007466:0.003772:0.013123:0.005792:0.003848:0.018049:0.013143:0.005792:0.003848:0.003848:0.010314:0.003772:0.013181:0.011699:0.012508:0.003772:0.006523:0.012604:0.003760:0.006523:0.011738:0.012508:0.003760:0.003848:0.013143:0.012450:0.009660:0.003772:0.012604:0.006042:0.003760:0.012450:0.012508:0.003848:0.003848:0.005330
specificity. Cytotoxic drugs kill any rapidly :@0.084242:0.444926:0.480469:0.444926:0.480469:0.429170:0.084242:0.429170:0.007466:0.013123:0.012508:0.012450:0.003848:0.004686:0.004686:0.012450:0.003848:0.006523:0.010314:0.005330:0.006639:0.015644:0.010314:0.006523:0.012604:0.006523:0.012604:0.009236:0.003848:0.012450:0.006631:0.013181:0.005792:0.011699:0.012950:0.007466:0.006633:0.009660:0.003848:0.003848:0.003848:0.006639:0.013143:0.011738:0.010314:0.006639:0.005792:0.013143:0.013123:0.003848:0.013181:0.003848:0.010314:0.005330
dividing cells, including tumour or normal :@0.084242:0.461197:0.480472:0.461197:0.480472:0.445441:0.084242:0.445441:0.013181:0.003848:0.010660:0.003848:0.013181:0.003848:0.011738:0.012950:0.007293:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330:0.007293:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.003848:0.011738:0.012950:0.007293:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007274:0.012604:0.005792:0.007279:0.011738:0.012604:0.006315:0.018049:0.013143:0.003848:0.005330
cells. Targeted therapies are designed to :@0.084242:0.477469:0.480495:0.477469:0.480495:0.461713:0.084242:0.461713:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330:0.007428:0.007197:0.013143:0.005807:0.012950:0.012508:0.006523:0.012508:0.013181:0.007428:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.003848:0.012508:0.007466:0.007428:0.013143:0.005713:0.012508:0.007428:0.013181:0.012508:0.007466:0.003848:0.012950:0.011738:0.012508:0.013181:0.007428:0.006523:0.012604:0.005330
affect specific cellular proteins, pathways, :@0.084242:0.493741:0.480478:0.493741:0.480478:0.477985:0.084242:0.477985:0.013143:0.006100:0.006042:0.012508:0.012450:0.006523:0.005036:0.007466:0.013123:0.012508:0.012450:0.003848:0.004686:0.004686:0.012450:0.005040:0.012450:0.012508:0.003848:0.003848:0.011699:0.003848:0.013143:0.005792:0.005045:0.013123:0.005715:0.012604:0.006523:0.012508:0.003848:0.011738:0.007466:0.005330:0.005042:0.013123:0.013143:0.006523:0.011738:0.015990:0.013143:0.010314:0.007466:0.005330:0.005330
or processes that are utilised primarily by :@0.084242:0.510013:0.480472:0.510013:0.480472:0.494257:0.084242:0.494257:0.012604:0.005792:0.007957:0.013123:0.005715:0.012604:0.012450:0.012508:0.007466:0.007466:0.012508:0.007466:0.007966:0.006523:0.011738:0.013143:0.006523:0.007966:0.013143:0.005715:0.012508:0.007966:0.011699:0.006523:0.003848:0.003848:0.003848:0.007466:0.012508:0.013181:0.007966:0.013123:0.005792:0.003848:0.018049:0.013143:0.005792:0.003848:0.003848:0.010314:0.007966:0.013123:0.010314:0.005330
malignant cells.  Although the toxic effects :@0.084242:0.526285:0.480494:0.526285:0.480494:0.510529:0.084242:0.510529:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.006523:0.004356:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330:0.004368:0.004356:0.014239:0.003848:0.006523:0.011738:0.012604:0.011699:0.012950:0.011738:0.004337:0.006523:0.011738:0.012508:0.004356:0.006523:0.012604:0.009236:0.003848:0.012450:0.004353:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466:0.005330
are often less severe than those seen with :@0.084242:0.542557:0.480486:0.542557:0.480486:0.526801:0.084242:0.526801:0.013143:0.005715:0.012508:0.005888:0.012604:0.006042:0.006523:0.012508:0.011738:0.005875:0.003848:0.012508:0.007466:0.007466:0.005888:0.007466:0.012508:0.010660:0.012508:0.005713:0.012508:0.005888:0.006523:0.011738:0.013143:0.011738:0.005879:0.006523:0.011738:0.012604:0.007466:0.012508:0.005879:0.007466:0.012508:0.012508:0.011738:0.005888:0.015990:0.003848:0.006523:0.011738:0.005330
cytotoxic chemotherapeutics, severe side :@0.084242:0.558829:0.480480:0.558829:0.480480:0.543073:0.084242:0.543073:0.012450:0.010314:0.006523:0.012604:0.006523:0.012604:0.009236:0.003848:0.012450:0.005328:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.012508:0.011699:0.006523:0.003848:0.012450:0.007466:0.005330:0.005324:0.007466:0.012508:0.010660:0.012508:0.005717:0.012508:0.005334:0.007466:0.003848:0.013181:0.012508:0.005330
effects may occur. Initially,  the targeted :@0.084242:0.575101:0.480480:0.575101:0.480480:0.559345:0.084242:0.559345:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466:0.009236:0.018049:0.013143:0.010314:0.009236:0.012604:0.012450:0.012450:0.011699:0.004376:0.005330:0.009236:0.004349:0.011738:0.003848:0.006523:0.003848:0.013143:0.003848:0.003848:0.010314:0.005330:0.005330:0.003924:0.006523:0.011738:0.012508:0.009236:0.006523:0.013143:0.005807:0.012950:0.012508:0.006523:0.012508:0.013181:0.005330
therapies were supposed to be selective :@0.084242:0.591372:0.480482:0.591372:0.480482:0.575616:0.084242:0.575616:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.003848:0.012508:0.007466:0.007857:0.015990:0.012508:0.005713:0.012508:0.007857:0.007466:0.011699:0.013123:0.013123:0.012604:0.007466:0.012508:0.013181:0.007870:0.006523:0.012604:0.007853:0.013123:0.012508:0.007859:0.007466:0.012508:0.003848:0.012508:0.012450:0.006523:0.003848:0.010660:0.012508:0.005330
for  one  specific  protein.  However,  there :@0.084242:0.607644:0.480484:0.607644:0.480484:0.591888:0.084242:0.591888:0.006042:0.012604:0.005792:0.005330:0.004972:0.012604:0.011738:0.012508:0.005330:0.004972:0.007466:0.013123:0.012508:0.012450:0.003848:0.004686:0.004686:0.012450:0.005330:0.004984:0.013123:0.005715:0.012604:0.006523:0.012508:0.003848:0.011738:0.005330:0.005330:0.004970:0.013143:0.012604:0.015990:0.012508:0.010660:0.012508:0.003766:0.005330:0.005330:0.004978:0.006523:0.011738:0.012508:0.005707:0.012508:0.005330
is usually a range  of  protein targets  to :@0.084242:0.623916:0.480497:0.623916:0.480497:0.608160:0.084242:0.608160:0.003848:0.007466:0.011372:0.011699:0.007466:0.011699:0.013143:0.003848:0.003848:0.010314:0.011372:0.013143:0.011372:0.005792:0.013143:0.011738:0.012950:0.012508:0.005330:0.006027:0.012604:0.006042:0.005330:0.006031:0.013123:0.005715:0.012604:0.006523:0.012508:0.003848:0.011738:0.011372:0.006523:0.013143:0.005807:0.012950:0.012508:0.006523:0.007466:0.005330:0.006031:0.006523:0.012604:0.005330
which a targeted drug can bind. Some :@0.084242:0.640188:0.480497:0.640188:0.480497:0.624432:0.084242:0.624432:0.015990:0.011738:0.003848:0.012450:0.011738:0.009660:0.013143:0.009660:0.006523:0.013143:0.005807:0.012950:0.012508:0.006523:0.012508:0.013181:0.009660:0.013181:0.005792:0.011699:0.012950:0.009660:0.012450:0.013143:0.011738:0.009660:0.013123:0.003848:0.011738:0.013181:0.005330:0.009660:0.009583:0.012604:0.018049:0.012508:0.005330
targeted therapies can bind to more than :@0.084242:0.656460:0.480499:0.656460:0.480499:0.640704:0.084242:0.640704:0.006523:0.013143:0.005805:0.012950:0.012508:0.006523:0.012508:0.013181:0.005122:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.003848:0.012508:0.007466:0.005128:0.012450:0.013143:0.011738:0.005138:0.013123:0.003848:0.011738:0.013181:0.005138:0.006523:0.012604:0.005126:0.018049:0.012604:0.005707:0.012508:0.005128:0.006523:0.011738:0.013143:0.011738:0.005330
one target (e.g., sorafenib or sunitinib).:@0.084242:0.672732:0.446571:0.672732:0.446571:0.656976:0.084242:0.656976:0.012604:0.011738:0.012508:0.005705:0.006523:0.013143:0.005805:0.012950:0.012508:0.006523:0.005715:0.007100:0.012508:0.005330:0.012950:0.005330:0.005330:0.005715:0.007466:0.012604:0.005792:0.013143:0.006042:0.012508:0.011738:0.003848:0.013123:0.005715:0.012604:0.005792:0.005705:0.007466:0.011699:0.011738:0.003848:0.006523:0.003848:0.011738:0.003848:0.013123:0.007100:0.005330
58-60:@0.446558:0.667244:0.475142:0.667244:0.475142:0.658058:0.446558:0.658058:0.006215:0.006215:0.003724:0.006215:0.006215
 :@0.475151:0.672863:0.480481:0.672863:0.480481:0.657107:0.475151:0.657107:0.005330
An example target for targeted therapy :@0.084242:0.689135:0.480491:0.689135:0.480491:0.673379:0.084242:0.673379:0.014239:0.011738:0.008871:0.012508:0.009236:0.013143:0.018049:0.013123:0.003848:0.012508:0.008871:0.006523:0.013143:0.005807:0.012950:0.012508:0.006523:0.008871:0.006042:0.012604:0.005792:0.008871:0.006523:0.013143:0.005805:0.012950:0.012508:0.006523:0.012508:0.013181:0.008871:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
is the  protein  produced  by the  Philadel-:@0.084242:0.705406:0.475149:0.705406:0.475149:0.689651:0.084242:0.689651:0.003848:0.007466:0.009044:0.006523:0.011738:0.012508:0.005330:0.003698:0.013123:0.005715:0.012604:0.006523:0.012508:0.003848:0.011738:0.005330:0.003698:0.013123:0.005711:0.012604:0.013181:0.011699:0.012450:0.012508:0.013181:0.005330:0.003700:0.013123:0.010314:0.009044:0.006523:0.011738:0.012508:0.005330:0.003702:0.011392:0.011738:0.003848:0.003848:0.013143:0.013181:0.012508:0.003848:0.006388
phia chromosome, a genetic lesion found :@0.084242:0.721678:0.480497:0.721678:0.480497:0.705922:0.084242:0.705922:0.013123:0.011738:0.003848:0.013143:0.005407:0.012450:0.011738:0.005713:0.012604:0.018049:0.012604:0.007466:0.012594:0.018049:0.012508:0.005330:0.005407:0.013143:0.005407:0.012950:0.012508:0.011738:0.012508:0.006523:0.003848:0.012450:0.005396:0.003848:0.012508:0.007466:0.003848:0.012604:0.011738:0.005407:0.006042:0.012604:0.011699:0.011738:0.013181:0.005330
commonly in chronic myeloid leukaemia. :@0.084242:0.737950:0.480475:0.737950:0.480475:0.722194:0.084242:0.722194:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.003848:0.010314:0.006754:0.003848:0.011738:0.006762:0.012450:0.011738:0.005709:0.012604:0.011738:0.003848:0.012450:0.006758:0.018049:0.010314:0.012508:0.003848:0.012604:0.003848:0.013181:0.006762:0.003848:0.012508:0.011699:0.009660:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.005330
This fusion protein (BCR-ABL protein) can :@0.084242:0.754222:0.480481:0.754222:0.480481:0.738466:0.084242:0.738466:0.008197:0.011738:0.003848:0.007466:0.008736:0.006042:0.011699:0.007466:0.003848:0.012604:0.011738:0.008736:0.013123:0.005715:0.012604:0.006523:0.012508:0.003848:0.011738:0.008736:0.007100:0.011045:0.015644:0.011680:0.006388:0.014239:0.011045:0.008890:0.008736:0.013123:0.005715:0.012604:0.006523:0.012508:0.003848:0.011738:0.007100:0.008736:0.012450:0.013143:0.011738:0.005330
be inhibited by imatinib; a small molecule :@0.084242:0.770494:0.480454:0.770494:0.480454:0.754738:0.084242:0.754738:0.013123:0.012508:0.005830:0.003848:0.011738:0.011738:0.003848:0.013123:0.003848:0.006523:0.012508:0.013181:0.005830:0.013123:0.010314:0.005830:0.003848:0.018049:0.013143:0.006523:0.003848:0.011738:0.003848:0.013123:0.005330:0.005830:0.013143:0.005830:0.007466:0.018049:0.013143:0.003848:0.003848:0.005842:0.018049:0.012604:0.003848:0.012508:0.012450:0.011699:0.003848:0.012508:0.005330
targeted therapy.:@0.084242:0.786766:0.251183:0.786766:0.251183:0.771010:0.084242:0.771010:0.006523:0.013143:0.005805:0.012950:0.012508:0.006523:0.012508:0.013181:0.005330:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
61:@0.251166:0.781187:0.263596:0.781187:0.263596:0.772001:0.251166:0.772001:0.006215:0.006215
IMMUNOTHERAPY:@0.084242:0.820008:0.282268:0.820008:0.282268:0.800411:0.084242:0.800411:0.006585:0.021167:0.021167:0.015052:0.017404:0.019756:0.009878:0.015993:0.012230:0.013641:0.017404:0.013170:0.014581
The human body’s immune system can :@0.084242:0.838578:0.480482:0.838578:0.480482:0.822822:0.084242:0.822822:0.008197:0.011738:0.012508:0.010622:0.011738:0.011699:0.018049:0.013143:0.011738:0.010622:0.013123:0.012604:0.013181:0.010314:0.006754:0.007466:0.010622:0.003848:0.018049:0.018049:0.011699:0.011738:0.012508:0.010622:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.010622:0.012450:0.013143:0.011738:0.005330
detect foreign bodies, infections and can-:@0.084242:0.854850:0.475165:0.854850:0.475165:0.839094:0.084242:0.839094:0.013181:0.012508:0.006523:0.012508:0.012450:0.006523:0.004637:0.006042:0.012604:0.005707:0.012508:0.003848:0.012950:0.011738:0.004641:0.013123:0.012604:0.013181:0.003848:0.012508:0.007466:0.005330:0.004657:0.003848:0.011738:0.006042:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.007466:0.004647:0.013143:0.011738:0.013181:0.004645:0.012450:0.013143:0.011738:0.006388
cer  cells and  produces  antibodies.  Anti-:@0.084242:0.871122:0.475158:0.871122:0.475158:0.855366:0.084242:0.855366:0.012450:0.012508:0.005792:0.005330:0.004101:0.012450:0.012508:0.003848:0.003848:0.007466:0.009448:0.013143:0.011738:0.013181:0.005330:0.004106:0.013123:0.005715:0.012604:0.013181:0.011699:0.012450:0.012508:0.007466:0.005330:0.004104:0.013143:0.011738:0.006523:0.003848:0.013123:0.012604:0.013181:0.003848:0.012508:0.007466:0.005330:0.005330:0.004108:0.014239:0.011738:0.006523:0.003848:0.006388
bodies are proteins that fight micro-organ-:@0.084242:0.887394:0.475152:0.887394:0.475152:0.871638:0.084242:0.871638:0.013123:0.012604:0.013181:0.003848:0.012508:0.007466:0.004630:0.013143:0.005713:0.012508:0.004622:0.013123:0.005715:0.012604:0.006523:0.012508:0.003848:0.011738:0.007466:0.004626:0.006523:0.011738:0.013143:0.006523:0.004620:0.004686:0.004686:0.012950:0.011738:0.006523:0.004612:0.018049:0.003848:0.012450:0.005717:0.012604:0.006388:0.012604:0.005792:0.012950:0.013143:0.011738:0.006388
isms and cancer. Monoclonal antibodies :@0.084242:0.903666:0.480476:0.903666:0.480476:0.887910:0.084242:0.887910:0.003848:0.007466:0.018049:0.007466:0.008447:0.013143:0.011738:0.013181:0.008447:0.012450:0.013143:0.011738:0.012450:0.012508:0.004376:0.005330:0.008447:0.017684:0.012604:0.011738:0.012604:0.012450:0.003848:0.012604:0.011738:0.013129:0.003848:0.008447:0.013143:0.011738:0.006523:0.003848:0.013123:0.012604:0.013181:0.003848:0.012508:0.007466:0.005330
are a specific type of treatment made in :@0.084242:0.919938:0.480478:0.919938:0.480478:0.904182:0.084242:0.904182:0.013143:0.005715:0.012508:0.006910:0.013143:0.006916:0.007466:0.013123:0.012508:0.012450:0.003848:0.004686:0.004686:0.012450:0.006910:0.006523:0.010314:0.013123:0.012508:0.006912:0.012604:0.006042:0.006908:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.006906:0.018049:0.013143:0.013181:0.012508:0.006914:0.003848:0.011738:0.005330
a laboratory. Monoclonal antibodies may :@0.084242:0.936210:0.480484:0.936210:0.480484:0.920454:0.084242:0.920454:0.013143:0.005954:0.003848:0.013143:0.013123:0.012604:0.005792:0.013143:0.006523:0.012604:0.005792:0.010314:0.005330:0.005942:0.017684:0.012604:0.011738:0.012604:0.012450:0.003848:0.012604:0.011738:0.013143:0.003848:0.005944:0.013143:0.011738:0.006523:0.003848:0.013123:0.012604:0.013181:0.003848:0.012508:0.007466:0.005965:0.018049:0.013143:0.010314:0.005330
be utilised in various forms. As discussed, :@0.523643:0.096131:0.919852:0.096131:0.919852:0.080375:0.523643:0.080375:0.013123:0.012508:0.008236:0.011699:0.006523:0.003848:0.003848:0.003848:0.007466:0.012508:0.013181:0.008236:0.003848:0.011738:0.008236:0.010660:0.013143:0.005792:0.003848:0.012604:0.011699:0.007466:0.008236:0.006042:0.012604:0.006319:0.018049:0.007466:0.005330:0.008236:0.014239:0.007466:0.008236:0.013181:0.003848:0.007466:0.012450:0.011699:0.007466:0.007466:0.012508:0.013181:0.005330:0.005330
monoclonal antibodies can be employed :@0.523643:0.112482:0.919880:0.112482:0.919880:0.096726:0.523643:0.096726:0.018049:0.012604:0.011738:0.012604:0.012450:0.003848:0.012604:0.011738:0.013143:0.003848:0.005294:0.013143:0.011738:0.006523:0.003848:0.013123:0.012604:0.013181:0.003848:0.012508:0.007466:0.005311:0.012450:0.013143:0.011738:0.005299:0.013123:0.012508:0.005299:0.012508:0.018049:0.013123:0.003848:0.012604:0.010314:0.012508:0.013181:0.005330
as a targeted therapy to block an abnor-:@0.523643:0.128834:0.914566:0.128834:0.914566:0.113078:0.523643:0.113078:0.013143:0.007466:0.006061:0.013143:0.006061:0.006523:0.013143:0.005805:0.012950:0.012508:0.006523:0.012508:0.013181:0.006052:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.006061:0.006523:0.012604:0.006052:0.013123:0.003848:0.012604:0.012450:0.009660:0.006061:0.013143:0.011738:0.006061:0.013143:0.013123:0.011738:0.012604:0.005792:0.006388
mal protein in a malignant cell. Mono-:@0.523643:0.145185:0.914552:0.145185:0.914552:0.129429:0.523643:0.129429:0.018049:0.013143:0.003848:0.011180:0.013123:0.005715:0.012604:0.006523:0.012508:0.003848:0.011738:0.011180:0.003848:0.011738:0.011180:0.013143:0.011180:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.006523:0.011180:0.012450:0.012508:0.003848:0.003848:0.005330:0.011180:0.017684:0.012604:0.011738:0.012623:0.006388
clonal antibodies can also be utilised as :@0.523643:0.161536:0.919863:0.161536:0.919863:0.145780:0.523643:0.145780:0.012450:0.003848:0.012604:0.011738:0.013143:0.003848:0.008621:0.013143:0.011738:0.006523:0.003848:0.013123:0.012604:0.013181:0.003848:0.012508:0.007466:0.008621:0.012450:0.013143:0.011738:0.008621:0.013143:0.003848:0.007466:0.012604:0.008621:0.013123:0.012508:0.008621:0.011699:0.006523:0.003848:0.003848:0.003848:0.007466:0.012508:0.013181:0.008621:0.013143:0.007466:0.005330
immunotherapy.  Some monoclonal an-:@0.523643:0.177887:0.914562:0.177887:0.914562:0.162131:0.523643:0.162131:0.003848:0.018049:0.018049:0.011699:0.011738:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005330:0.007937:0.009583:0.012604:0.018049:0.012508:0.013277:0.018049:0.012604:0.011738:0.012604:0.012450:0.003848:0.012604:0.011738:0.013143:0.003848:0.013277:0.013143:0.011738:0.006388
tibodies,  when  attached  to  specific  pro-:@0.523643:0.194239:0.914556:0.194239:0.914556:0.178483:0.523643:0.178483:0.006523:0.003848:0.013123:0.012604:0.013181:0.003848:0.012508:0.007466:0.005330:0.005330:0.003300:0.015990:0.011738:0.012508:0.011738:0.005330:0.003296:0.013143:0.006523:0.006523:0.013143:0.012450:0.011738:0.012508:0.013181:0.005330:0.003292:0.006523:0.012604:0.005330:0.003290:0.007466:0.013123:0.012508:0.012450:0.003848:0.004686:0.004686:0.012450:0.005330:0.003296:0.013123:0.005715:0.012604:0.006388
teins  on  cancer  cells,  flag  the  malignant :@0.523643:0.210590:0.919896:0.210590:0.919896:0.194834:0.523643:0.194834:0.006523:0.012508:0.003848:0.011738:0.007466:0.005330:0.002969:0.012604:0.011738:0.005330:0.002969:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.002965:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330:0.005330:0.002975:0.004666:0.004666:0.013143:0.012950:0.005330:0.002967:0.006523:0.011738:0.012508:0.005330:0.002967:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.006523:0.005330
cells and the immune system can detect :@0.523643:0.226941:0.919882:0.226941:0.919882:0.211185:0.523643:0.211185:0.012450:0.012508:0.003848:0.003848:0.007466:0.007120:0.013143:0.011738:0.013181:0.007120:0.006523:0.011738:0.012508:0.007120:0.003848:0.018049:0.018049:0.011699:0.011738:0.012508:0.007120:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.007120:0.012450:0.013143:0.011738:0.007120:0.013181:0.012508:0.006523:0.012508:0.012450:0.006523:0.005330
and kill those cells.  :@0.523643:0.243292:0.705849:0.243292:0.705849:0.227536:0.523643:0.227536:0.013143:0.011738:0.013181:0.005330:0.009660:0.003848:0.003848:0.003848:0.005330:0.006523:0.011738:0.012604:0.007466:0.012508:0.005330:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330:0.005330:0.005330
Other types of monoclonal antibodies :@0.541827:0.259644:0.919882:0.259644:0.919882:0.243888:0.541827:0.243888:0.016722:0.006523:0.011738:0.012508:0.005792:0.010064:0.006523:0.010314:0.013123:0.012508:0.007466:0.010064:0.012604:0.006042:0.010064:0.018049:0.012604:0.011738:0.012604:0.012450:0.003848:0.012604:0.011738:0.013143:0.003848:0.010064:0.013143:0.011738:0.006523:0.003848:0.013123:0.012604:0.013181:0.003848:0.012508:0.007466:0.005330
work by releasing the brakes on the im-:@0.523643:0.275995:0.914548:0.275995:0.914548:0.260239:0.523643:0.260239:0.015990:0.012604:0.005792:0.009660:0.009121:0.013123:0.010314:0.009121:0.005711:0.012508:0.003848:0.012508:0.013143:0.007466:0.003848:0.011738:0.012950:0.009121:0.006523:0.011738:0.012508:0.009121:0.013123:0.005792:0.013143:0.009660:0.012508:0.007466:0.009121:0.012604:0.011738:0.009121:0.006523:0.011738:0.012508:0.009121:0.003848:0.018049:0.006388
mune system so it can destroy cancer cells. :@0.523643:0.292346:0.919888:0.292346:0.919888:0.276590:0.523643:0.276590:0.018049:0.011699:0.011738:0.012508:0.003562:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.003579:0.007466:0.012604:0.003568:0.003848:0.006523:0.003579:0.012450:0.013143:0.011738:0.003568:0.013181:0.012508:0.007466:0.006523:0.005713:0.012604:0.010314:0.003568:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.003562:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330:0.005330
The PD-1/PD-L1 and CTLA-4 pathways are :@0.523643:0.308697:0.919880:0.308697:0.919880:0.292941:0.523643:0.292941:0.008197:0.011738:0.012508:0.006146:0.011392:0.014316:0.006388:0.010660:0.008409:0.011392:0.014316:0.006388:0.008890:0.010660:0.006158:0.013143:0.011738:0.013181:0.006158:0.015644:0.008197:0.008890:0.014239:0.006388:0.010660:0.006148:0.013123:0.013143:0.006523:0.011738:0.015990:0.013143:0.010314:0.007466:0.006158:0.013143:0.005715:0.012508:0.005330
crucial to the immune system’s capacity :@0.523643:0.325049:0.919865:0.325049:0.919865:0.309293:0.523643:0.309293:0.012450:0.005792:0.011699:0.012450:0.003848:0.013143:0.003848:0.008072:0.006523:0.012604:0.008061:0.006523:0.011738:0.012508:0.008063:0.003848:0.018049:0.018049:0.011699:0.011738:0.012508:0.008066:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.006754:0.007466:0.008072:0.012450:0.013143:0.013123:0.013143:0.012450:0.003848:0.006523:0.010314:0.005330
to control cancer growth. These pathways :@0.523643:0.341400:0.919875:0.341400:0.919875:0.325644:0.523643:0.325644:0.006523:0.012604:0.004705:0.012450:0.012604:0.011738:0.006523:0.005702:0.012604:0.003848:0.004714:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.004703:0.012950:0.005709:0.012604:0.015990:0.006523:0.011738:0.005330:0.004699:0.008197:0.011738:0.012508:0.007466:0.012508:0.004705:0.013123:0.013143:0.006523:0.011738:0.015990:0.013143:0.010314:0.007466:0.005330
are often referred to as “immune check-:@0.523643:0.357751:0.914575:0.357751:0.914575:0.341995:0.523643:0.341995:0.013143:0.005715:0.012508:0.007620:0.012604:0.006042:0.006523:0.012498:0.011738:0.007620:0.005713:0.012508:0.006042:0.012508:0.005792:0.005711:0.012508:0.013181:0.007620:0.006523:0.012604:0.007620:0.013143:0.007466:0.007620:0.009660:0.003848:0.018049:0.018049:0.011699:0.011738:0.012508:0.007620:0.012450:0.011738:0.012508:0.012450:0.009660:0.006388
points.” Many cancers overexpress these :@0.523643:0.374102:0.919894:0.374102:0.919894:0.358346:0.523643:0.358346:0.013123:0.012604:0.003848:0.011738:0.006523:0.007466:0.005330:0.009313:0.008070:0.017684:0.013143:0.011738:0.010314:0.008082:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466:0.008070:0.012604:0.010660:0.012508:0.005711:0.012508:0.009236:0.013123:0.005715:0.012508:0.007466:0.007466:0.008082:0.006523:0.011738:0.012508:0.007466:0.012508:0.005330
pathways to evade the immune system :@0.523643:0.390454:0.919882:0.390454:0.919882:0.374698:0.523643:0.374698:0.013123:0.013143:0.006523:0.011738:0.015990:0.013143:0.010314:0.007466:0.009871:0.006523:0.012604:0.009871:0.012508:0.010660:0.013143:0.013181:0.012508:0.009871:0.006523:0.011738:0.012508:0.009871:0.003848:0.018049:0.018049:0.011699:0.011738:0.012508:0.009871:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.005330
and immune surveillance. Monoclonal :@0.523643:0.406805:0.919902:0.406805:0.919902:0.391049:0.523643:0.391049:0.013143:0.011738:0.013181:0.016625:0.003848:0.018049:0.018049:0.011699:0.011738:0.012508:0.016625:0.007466:0.011699:0.005792:0.010660:0.012508:0.003848:0.003848:0.003848:0.013143:0.011738:0.012450:0.012508:0.005330:0.016625:0.017684:0.012604:0.011738:0.012604:0.012450:0.003848:0.012604:0.011738:0.013143:0.003848:0.005330
antibodies can block immune checkpoint :@0.523643:0.423156:0.919902:0.423156:0.919902:0.407400:0.523643:0.407400:0.013143:0.011738:0.006523:0.003848:0.013123:0.012604:0.013181:0.003848:0.012508:0.007466:0.005349:0.012450:0.013143:0.011738:0.005349:0.013123:0.003848:0.012604:0.012450:0.009660:0.005349:0.003848:0.018049:0.018049:0.011699:0.011738:0.012508:0.005349:0.012450:0.011738:0.012508:0.012450:0.009660:0.013123:0.012604:0.003848:0.011738:0.006523:0.005330
pathways overexpressed in tumours.  The :@0.523643:0.439507:0.919880:0.439507:0.919880:0.423751:0.523643:0.423751:0.013123:0.013143:0.006523:0.011738:0.015990:0.013143:0.010314:0.007466:0.009275:0.012604:0.010660:0.012508:0.005709:0.012508:0.009236:0.013123:0.005713:0.012508:0.007466:0.007466:0.012508:0.013181:0.009275:0.003848:0.011738:0.009275:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.005330:0.003931:0.008197:0.011738:0.012508:0.005330
following monoclonal antibodies are  im-:@0.523643:0.455859:0.914552:0.455859:0.914552:0.440103:0.523643:0.440103:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.003848:0.011738:0.012950:0.007433:0.018049:0.012604:0.011738:0.012604:0.012450:0.003848:0.012604:0.011738:0.013143:0.003848:0.007428:0.013143:0.011738:0.006523:0.003848:0.013123:0.012604:0.013181:0.003848:0.012508:0.007466:0.007447:0.013143:0.005715:0.012508:0.007433:0.007435:0.003848:0.018049:0.006388
mune  checkpoint  inhibitors:    ipilimumab :@0.523643:0.472210:0.919869:0.472210:0.919869:0.456454:0.523643:0.456454:0.018049:0.011699:0.011738:0.012508:0.005330:0.005120:0.012450:0.011738:0.012508:0.012450:0.009660:0.013123:0.012604:0.003848:0.011738:0.006523:0.005330:0.005126:0.003848:0.011738:0.011738:0.003848:0.013123:0.003848:0.006523:0.012604:0.005792:0.007466:0.005330:0.005330:0.005126:0.005330:0.005126:0.003848:0.013123:0.003848:0.003848:0.003848:0.018049:0.011699:0.018049:0.013143:0.013123:0.005330
(anti-CTLA-4), nivolumab and pembroli-:@0.523643:0.488561:0.914535:0.488561:0.914535:0.472805:0.523643:0.472805:0.007100:0.013143:0.011738:0.006523:0.003848:0.006388:0.015644:0.008197:0.008890:0.014239:0.006388:0.010660:0.007100:0.005330:0.013239:0.011738:0.003848:0.010660:0.012604:0.003848:0.011699:0.018049:0.013143:0.013123:0.013239:0.013143:0.011738:0.013181:0.013239:0.013123:0.012508:0.018049:0.013123:0.005717:0.012604:0.003848:0.003848:0.006388
zumab (anti-PD1).:@0.523643:0.504912:0.696901:0.504912:0.696901:0.489156:0.523643:0.489156:0.008178:0.011699:0.018049:0.013143:0.013123:0.011526:0.007100:0.013143:0.011738:0.006523:0.003848:0.006388:0.011392:0.014316:0.010660:0.007100:0.005330
62, 63:@0.696902:0.499479:0.727110:0.499479:0.727110:0.490293:0.696902:0.490293:0.006215:0.006215:0.003107:0.002242:0.006215:0.006215
 Checkpoint inhibi-:@0.727120:0.505098:0.914541:0.505098:0.914541:0.489342:0.727120:0.489342:0.011526:0.015644:0.011738:0.012508:0.012450:0.009660:0.013123:0.012604:0.003848:0.011738:0.006523:0.011526:0.003848:0.011738:0.011738:0.003848:0.013123:0.003848:0.006388
tor toxicities, referred to as immune-relat-:@0.523631:0.521449:0.914527:0.521449:0.914527:0.505693:0.523631:0.505693:0.006523:0.012604:0.005792:0.007533:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.003848:0.012508:0.007466:0.005330:0.007543:0.005713:0.012508:0.006042:0.012508:0.005792:0.005703:0.012508:0.013181:0.007543:0.006523:0.012604:0.007543:0.013143:0.007466:0.007543:0.003848:0.018049:0.018049:0.011699:0.011738:0.012508:0.006388:0.005705:0.012508:0.003848:0.013143:0.006523:0.006388
ed adverse events, include skin adverse :@0.523631:0.537800:0.919871:0.537800:0.919871:0.522044:0.523631:0.522044:0.012508:0.013181:0.009198:0.013143:0.013181:0.010660:0.012508:0.005792:0.007466:0.012508:0.009198:0.012508:0.010660:0.012508:0.011738:0.006523:0.007466:0.005330:0.009198:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.009198:0.007466:0.009660:0.003848:0.011738:0.009198:0.013143:0.013181:0.010660:0.012508:0.005792:0.007466:0.012508:0.005330
events, gastro-intestinal toxicities (colitis), :@0.523631:0.554152:0.919850:0.554152:0.919850:0.538396:0.523631:0.538396:0.012508:0.010660:0.012508:0.011738:0.006523:0.007466:0.005330:0.009737:0.012950:0.013143:0.007466:0.006523:0.005713:0.012604:0.006388:0.003848:0.011738:0.006523:0.012508:0.007466:0.006523:0.003848:0.011738:0.013143:0.003848:0.009737:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.003848:0.012508:0.007466:0.009737:0.007100:0.012450:0.012604:0.003848:0.003848:0.006523:0.003848:0.007466:0.007100:0.005330:0.005330
oral complications, pulmonary toxicities, :@0.523631:0.570503:0.919871:0.570503:0.919871:0.554747:0.523631:0.554747:0.012604:0.005792:0.013143:0.003848:0.011334:0.012450:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.011334:0.013123:0.011699:0.003848:0.018049:0.012604:0.011738:0.013143:0.005792:0.010314:0.011334:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.003848:0.012508:0.007466:0.005330:0.005330
and endocrinological complications (thy-:@0.523631:0.586854:0.914539:0.586854:0.914539:0.571098:0.523631:0.571098:0.013143:0.011738:0.013181:0.006646:0.012508:0.011738:0.013181:0.012604:0.012450:0.005792:0.003848:0.011738:0.012588:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.006658:0.012450:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.006644:0.007100:0.006523:0.011738:0.010314:0.006388
roiditis and hypophysitis).:@0.523631:0.603205:0.753923:0.603205:0.753923:0.587449:0.523631:0.587449:0.005713:0.012604:0.003848:0.013181:0.003848:0.006523:0.003848:0.007466:0.005330:0.013143:0.011738:0.013181:0.005330:0.011738:0.010314:0.013123:0.012604:0.013123:0.011738:0.010314:0.007466:0.003848:0.006523:0.003848:0.007466:0.007100:0.005330
64, 65:@0.753943:0.597622:0.784152:0.597622:0.784152:0.588437:0.753943:0.588437:0.006215:0.006215:0.003107:0.002242:0.006215:0.006215
 :@0.784162:0.603241:0.789492:0.603241:0.789492:0.587486:0.784162:0.587486:0.005330
REFERENCES:@0.523639:0.633020:0.634475:0.633020:0.634475:0.616987:0.523639:0.616987:0.011161:0.010006:0.009236:0.010006:0.011161:0.010006:0.014239:0.015009:0.010006:0.010006
1.:@0.523636:0.649932:0.537850:0.649932:0.537850:0.635927:0.523636:0.635927:0.009476:0.004738
Tripathy D, Henderson IC. Systemic  adju-:@0.559983:0.649932:0.914532:0.649932:0.914532:0.635927:0.559983:0.635927:0.006773:0.005148:0.003421:0.011665:0.011682:0.005798:0.010434:0.009168:0.009253:0.012726:0.004738:0.009253:0.011682:0.011118:0.010434:0.011716:0.011118:0.005148:0.006636:0.011203:0.010434:0.009253:0.003866:0.013906:0.004738:0.009253:0.008518:0.009168:0.006636:0.005798:0.011118:0.016044:0.003421:0.011067:0.004738:0.004526:0.011682:0.011716:0.003472:0.010399:0.005679
vant therapy for breast cancer. :@0.559983:0.664231:0.831150:0.664231:0.831150:0.650226:0.559983:0.650226:0.009476:0.011682:0.010434:0.005798:0.006585:0.005798:0.010434:0.011118:0.005148:0.011682:0.011665:0.009168:0.006585:0.005371:0.011203:0.005148:0.006575:0.011665:0.005080:0.011118:0.011682:0.006636:0.005798:0.006585:0.011067:0.011682:0.010434:0.011067:0.011118:0.003888:0.004738:0.004738
Curr Opin :@0.832997:0.664231:0.919294:0.664231:0.919294:0.650226:0.832997:0.650226:0.013906:0.010399:0.005148:0.005148:0.006573:0.014864:0.011665:0.003421:0.010434:0.004738
Oncol.:@0.559983:0.678531:0.615709:0.678531:0.615709:0.664525:0.559983:0.664525:0.014864:0.010434:0.011067:0.011203:0.003421:0.004738
 1992 Dec;4(6):1041-9.:@0.615709:0.678531:0.796844:0.678531:0.796844:0.664525:0.615709:0.664525:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.012726:0.011118:0.011067:0.004738:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.004738
2.:@0.523636:0.692830:0.537850:0.692830:0.537850:0.678825:0.523636:0.678825:0.009476:0.004738
Lippman ME.  An  assessment  of  current :@0.559983:0.692830:0.919289:0.692830:0.919289:0.678825:0.559983:0.678825:0.007902:0.003421:0.011665:0.011665:0.016044:0.011682:0.010434:0.012144:0.015719:0.009168:0.004738:0.004738:0.007398:0.012657:0.010434:0.004738:0.007394:0.011682:0.006636:0.006636:0.011118:0.006636:0.006636:0.016044:0.011128:0.010434:0.005798:0.004738:0.007396:0.011203:0.005371:0.004738:0.007396:0.011067:0.010399:0.005148:0.005071:0.011118:0.010434:0.005798:0.004738
achievements in the  systemic manage-:@0.559983:0.707129:0.914559:0.707129:0.914559:0.693124:0.559983:0.693124:0.011682:0.011067:0.010434:0.003421:0.011118:0.009476:0.011118:0.016044:0.011118:0.010434:0.005798:0.006636:0.011751:0.003421:0.010434:0.011751:0.005798:0.010434:0.011118:0.004738:0.006999:0.006636:0.009168:0.006636:0.005798:0.011118:0.016044:0.003421:0.011067:0.011751:0.016044:0.011682:0.010434:0.011682:0.011511:0.011118:0.005679
ment of breast cancer. :@0.559983:0.721428:0.759136:0.721428:0.759136:0.707423:0.559983:0.707423:0.016044:0.011118:0.010434:0.005798:0.006158:0.011203:0.005371:0.006158:0.011665:0.005080:0.011118:0.011682:0.006636:0.005798:0.006158:0.011067:0.011682:0.010434:0.011067:0.011118:0.003890:0.004738:0.004738
Breast Cancer Res :@0.760555:0.721428:0.919301:0.721428:0.919301:0.707423:0.760555:0.707423:0.009818:0.005148:0.011118:0.011682:0.006636:0.005798:0.006158:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.006158:0.010382:0.011118:0.006636:0.004738
Treat.:@0.559983:0.735728:0.605754:0.735728:0.605754:0.721722:0.559983:0.721722:0.007286:0.005148:0.011118:0.011682:0.005798:0.004738
 1984;4(2):69-77.:@0.605737:0.735728:0.737748:0.735728:0.737748:0.721722:0.605737:0.721722:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
3.:@0.523636:0.750027:0.537850:0.750027:0.537850:0.736022:0.523636:0.736022:0.009476:0.004738
Wu C. Systemic Therapy for Colon Cancer.:@0.559983:0.750027:0.914570:0.750027:0.914570:0.736022:0.559983:0.736022:0.015397:0.009886:0.008261:0.013393:0.004225:0.008261:0.008005:0.008655:0.006123:0.005285:0.010605:0.015531:0.002908:0.010553:0.008261:0.006773:0.009921:0.010605:0.004635:0.011169:0.011152:0.008655:0.008261:0.004858:0.010690:0.004635:0.008261:0.013393:0.010690:0.002908:0.010690:0.009921:0.008261:0.013393:0.011169:0.009921:0.010553:0.010605:0.003380:0.004738
Surg Oncol Clin N Am:@0.559983:0.764326:0.728084:0.764326:0.728084:0.750321:0.559983:0.750321:0.008005:0.009886:0.004635:0.010998:0.004173:0.014351:0.009921:0.010553:0.010690:0.002908:0.004173:0.013393:0.002908:0.002908:0.009921:0.004173:0.012144:0.004173:0.012144:0.016044
. 2018 Apr;27(2):235-242.:@0.727571:0.764326:0.914539:0.764326:0.914539:0.750321:0.727571:0.750321:0.004225:0.004173:0.008963:0.008963:0.008963:0.008963:0.004173:0.012144:0.011152:0.004635:0.004225:0.008963:0.008963:0.005798:0.008963:0.005798:0.004225:0.008963:0.008963:0.008963:0.005166:0.008963:0.008963:0.008963:0.004738
4.:@0.523636:0.778625:0.537850:0.778625:0.537850:0.764620:0.523636:0.764620:0.009476:0.004738
Rapoport  BL,  Demetriou  GS,  Moodley  SD, :@0.559983:0.778625:0.919279:0.778625:0.919279:0.764620:0.559983:0.764620:0.010382:0.011682:0.011665:0.011203:0.011665:0.011203:0.005148:0.005798:0.004738:0.002993:0.009818:0.007902:0.004738:0.004738:0.002998:0.012726:0.011118:0.016044:0.011118:0.005798:0.005148:0.003421:0.011203:0.010399:0.004738:0.002993:0.014915:0.008518:0.004738:0.004738:0.003002:0.015719:0.011203:0.011203:0.011716:0.003421:0.011118:0.009168:0.004738:0.002998:0.008518:0.012726:0.004738:0.004738
Benn CA. When and how do I use neoad-:@0.559983:0.792925:0.914587:0.792925:0.914587:0.778919:0.559983:0.778919:0.009818:0.011118:0.010434:0.010434:0.005833:0.013906:0.012657:0.004738:0.005833:0.016420:0.010434:0.011118:0.010434:0.005821:0.011682:0.010434:0.011716:0.005833:0.010434:0.011203:0.014214:0.005824:0.011716:0.011203:0.005833:0.003866:0.005833:0.010399:0.006636:0.011118:0.005833:0.010434:0.011118:0.011203:0.011682:0.011716:0.005679
juvant chemotherapy for  breast cancer? :@0.559983:0.807224:0.919302:0.807224:0.919302:0.793219:0.559983:0.793219:0.003472:0.010399:0.009476:0.011682:0.010434:0.005798:0.008535:0.011067:0.010434:0.011118:0.016044:0.011203:0.005798:0.010434:0.011104:0.005148:0.011682:0.011665:0.009168:0.008535:0.005371:0.011203:0.005148:0.004738:0.003785:0.011665:0.005080:0.011118:0.011682:0.006636:0.005798:0.008535:0.011067:0.011682:0.010434:0.011067:0.011118:0.005148:0.010109:0.004738
Curr  Treat Options Oncol.:@0.559983:0.821523:0.780449:0.821523:0.780449:0.807518:0.559983:0.807518:0.013906:0.010399:0.005148:0.005148:0.004738:0.003618:0.007286:0.005148:0.011118:0.011682:0.005798:0.008364:0.014864:0.011665:0.005798:0.003421:0.011203:0.010434:0.006636:0.008364:0.014864:0.010434:0.011067:0.011203:0.003421:0.004738
 2014;Mar;15(1): :@0.780449:0.821523:0.919279:0.821523:0.919279:0.807518:0.780449:0.807518:0.008364:0.009476:0.009476:0.009476:0.009476:0.004738:0.015729:0.011682:0.005148:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.004738
86-98.:@0.559983:0.835822:0.608302:0.835822:0.608302:0.821817:0.559983:0.821817:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738
5.:@0.523636:0.850122:0.537850:0.850122:0.537850:0.836116:0.523636:0.836116:0.009476:0.004738
Lo Nigro C, Denaro N, Merlotti A, Merlano :@0.559983:0.850122:0.919318:0.850122:0.919318:0.836116:0.559983:0.836116:0.007731:0.011032:0.007321:0.012486:0.003250:0.011340:0.004907:0.011032:0.007321:0.013735:0.004567:0.007321:0.012555:0.010947:0.010263:0.011511:0.004906:0.011032:0.007321:0.012486:0.004567:0.007321:0.015548:0.010947:0.004977:0.003250:0.011032:0.005627:0.005627:0.003250:0.007321:0.012486:0.004567:0.007321:0.015548:0.010947:0.004977:0.003250:0.011511:0.010263:0.011198:0.004738
M. Head and neck cancer: improving out-:@0.559983:0.864421:0.914554:0.864421:0.914554:0.850416:0.559983:0.850416:0.015548:0.004567:0.006294:0.011511:0.010947:0.011511:0.011545:0.006294:0.011511:0.010263:0.011545:0.006294:0.010263:0.010947:0.010895:0.008415:0.006294:0.010895:0.011511:0.010263:0.010895:0.010947:0.004977:0.004567:0.006294:0.003250:0.015873:0.011494:0.004907:0.011032:0.009305:0.003250:0.010263:0.011340:0.006294:0.011032:0.010228:0.005627:0.005679
comes with a multidisciplinary approach. :@0.559983:0.878720:0.919255:0.878720:0.919255:0.864715:0.559983:0.864715:0.010895:0.011032:0.015873:0.010947:0.006465:0.009852:0.014043:0.003250:0.005627:0.010263:0.009852:0.011511:0.009852:0.015873:0.010228:0.003250:0.005627:0.003250:0.011545:0.003250:0.006465:0.010895:0.003250:0.011494:0.003250:0.003250:0.010263:0.011511:0.004977:0.008997:0.009852:0.011511:0.011494:0.011494:0.004906:0.011032:0.011511:0.010895:0.010263:0.004736:0.004738
Cancer Manag Res:@0.559983:0.893019:0.719412:0.893019:0.719412:0.879014:0.559983:0.879014:0.013735:0.011511:0.010263:0.010895:0.010947:0.004977:0.004567:0.015548:0.011511:0.010263:0.011511:0.011340:0.004567:0.010211:0.010947:0.006636
. 2017 Aug;18;9:363-371.:@0.719241:0.893019:0.911905:0.893019:0.911905:0.879014:0.719241:0.879014:0.004567:0.004567:0.009305:0.009305:0.009305:0.009305:0.004567:0.012486:0.010228:0.011340:0.004567:0.009305:0.009305:0.004567:0.009305:0.004567:0.009305:0.009305:0.009305:0.005508:0.009305:0.009305:0.009305:0.004738
6.:@0.523636:0.907319:0.537850:0.907319:0.537850:0.893313:0.523636:0.893313:0.009476:0.004738
Dai  T, Shah MA. Chemoradiation in oe-:@0.559983:0.907319:0.914561:0.907319:0.914561:0.893313:0.559983:0.893313:0.012726:0.011682:0.003421:0.004738:0.005809:0.005537:0.004738:0.010536:0.008518:0.010434:0.011682:0.010434:0.010536:0.015719:0.012657:0.004738:0.010536:0.013906:0.010434:0.011118:0.016044:0.011203:0.005148:0.011682:0.011716:0.003421:0.011682:0.005798:0.003421:0.011203:0.010434:0.010536:0.003421:0.010434:0.010536:0.011203:0.011118:0.005679
sophageal cancer. :@0.559983:0.921618:0.722359:0.921618:0.722359:0.907613:0.559983:0.907613:0.006636:0.011203:0.011665:0.010434:0.011682:0.011511:0.011118:0.011682:0.003421:0.004293:0.011067:0.011682:0.010434:0.011067:0.011118:0.003888:0.004738:0.004738
Best Pract Res Clin Gas-:@0.721915:0.921618:0.914520:0.921618:0.914520:0.907613:0.721915:0.907613:0.009818:0.011118:0.006636:0.005798:0.004293:0.010126:0.005148:0.011682:0.011067:0.005798:0.004293:0.010382:0.011118:0.006636:0.004293:0.013906:0.003421:0.003421:0.010434:0.004303:0.014915:0.011682:0.006636:0.005679
troenterol.:@0.559983:0.935917:0.645111:0.935917:0.645111:0.921912:0.559983:0.921912:0.005798:0.005148:0.011203:0.011118:0.010434:0.005798:0.011118:0.005148:0.011203:0.003421:0.004738
 2015 Feb;29(1):193-209.:@0.645094:0.935917:0.841349:0.935917:0.841349:0.921912:0.645094:0.921912:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.008296:0.011118:0.011665:0.004738:0.009476:0.009476:0.006312:0.009476:0.006312:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738